Φορτώνει......
LILRB4 Expression in Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome Based on Response to Hypomethylating Agents
LILRB4 is expressed on AML M4/M5 cells and negatively regulates immune cell activation via T cell suppression. Its expression and role in CMML and MDS are unknown. We investigated LILRB4 expression in 19 CMML and 27 MDS patients and correlated it with response to subsequent HMA therapy. LILRB4 RNA e...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Leuk Lymphoma |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7836710/ https://ncbi.nlm.nih.gov/pubmed/32036728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2020.1723014 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|